Go to deals
Healthcare | Private Equity

Acutronic Group have been acquired by Vyaire Medical Inc.

Acutronic Group, a group of non-affiliated companies active in neonatal ventilation, has been acquired by Apax-backed Vyaire Medical Inc., the leading pure play medical device company in the respiratory space. Financial details have not been disclosed.

Acutronic Group, consisting of Acutronic Medical Systems AG (Switzerland) and MIM Medizinische Instrumente & Monitoring GmbH, (Germany), is a global innovation leader in the area of neonatal ventilation. The group's portfolio includes the fabian® ventilator platform, the monsoon® jet ventilator, the florian® monitor and complimentary airway management devices and software solutions. Acutronic Group has a high vertical integration in that all performance-critical device components and the disposable flow sensors are manufactured in-house. In recent years, innovative Acutronic Group has grown much faster than the market, taking significant market share away from large competitors in the global neonatal intensive care market. Founded in 1981, the company is located in Germany and Switzerland and its products are distributed in more than 90 countries.

Vyaire Medical is the leading pure play medical device company in the respiratory space. With approximately US$800 million in annual sales, the company is active in manufacturing and distributing both respiratory and anesthesia/surgical consumables as well as capital equipment for respiratory diagnostics and ventilation. Headquartered in Chicago, Illinois, Vyaire Medical was formed in October 2016 as a joint venture between Becton, Dickinson and Company and Apax Partners to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia business lines. Vyaire's brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring. From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others – Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.

Oaklins' team in Germany advised the private shareholders of Acutronic Medical Systems AG and MIM Medizinische Instrumente & Monitoring GmbH throughout the whole transaction process.

Parties

Talk to the deal team

Jan P. Hatje

Managing Partner
Hamburg, Germany
Oaklins Germany

Christian Jellentrup

Director
Hamburg, Germany
Oaklins Germany

Related deals

Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more
Mark Climate Technology has acquired Heber GmbH
Private Equity | Industrial Machinery & Components | Other Industries

Mark Climate Technology has acquired Heber GmbH

Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.

Learn more
Grupo Veta 2017 S.L. has been acquired by MSA Mizar
Private Equity | Business Support Services | Financial Services | TMT

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.

Learn more